<p>Teladoc Health（纽约证券交易所代码：TDOC - 获取免费报告）预计将在 2026 年 4 月 29 日星期三市场收盘后发布其 2026 年第一季度财报。分析师预计 Teladoc Health 将在本季度发布每股收益（EPS）为（$0.3412）和收入为 6.138170 亿美元。Teladoc Health 已将其 2026 年第一季度的指导范围设定为每股收益-0.450 至-0.350，并将其 2026 财年的指导范围设定为每股收益-1.100 至-0.700。个人可以查看公司即将发布的 2026 年第一季度财报的信息，以获取有关定于 2026 年 4 月 29 日下午 5:00（东部时间）的电话会议的最新详情。</p>
<p>获取 <strong>Teladoc Health</strong> 警报：</p>
<ul>
<li>Peloton 股票正在上涨，但它能否再交付 70% 的上涨空间？</li>
</ul>
<p>Teladoc Health（纽约证券交易所代码：TDOC - 获取免费报告）最近在 2026 年 2 月 25 日星期三发布了季度财报。该健康服务提供商报告本季度每股收益（EPS）为（$0.14），超出市场共识预期的（$0.19）$0.05。Teladoc Health 的股本回报率为-9.13%，净利润率为-7.92%。该公司本季度的收入为 6.4227 亿美元，而分析师预期为 6.3533 亿美元。去年同期，该公司每股收益为（$0.28）。该公司的季度收入较去年同期增长了 0.3%。分析师平均预计 Teladoc Health 在当前财年的每股收益为-$1，在下一个财年的每股收益也为-$1。</p>
<h2>Teladoc Health 股票下跌 1.7%</h2>
<p>Teladoc Health 股票在星期三开盘价为 6.00 美元。Teladoc Health 的 52 周低点为 4.40 美元，52 周高点为 9.77 美元。该公司的债务与股本比率为 0.72，速动比率为 2.67，流动比率为 2.77。该公司的市值为 10.8 亿美元，市盈率为-5.26，贝塔系数为 2.07。该股票的 50 日简单移动平均线为 5.22 美元，200 日简单移动平均线为 6.57 美元。</p>
<h2>Teladoc Health 的内部买卖</h2>
<ul>
<li>2 只可能受益于特朗普新 FDA 任命的远程医疗股票</li>
</ul>
<p>在相关消息中，首席执行官 Charles Divita III 在 2026 年 3 月 11 日星期三出售了 27,731 股 Teladoc Health 股票。该股票以平均价格 5.49 美元出售，总价值为 152,243.19 美元。交易后，首席执行官直接持有该公司 364,784 股股票，价值 2,002,664.16 美元。此交易代表其持股减少了 7.06%。该交易已在向 SEC 的备案中披露，相关信息可在 SEC 网站上查阅。目前，0.70% 的股票由公司内部人士持有。</p>
<h2>Teladoc Health 的机构交易</h2>
<p>对冲基金最近对该公司的持仓进行了调整。Dimensional Fund Advisors LP 在第四季度将其在 Teladoc Health 的股份增加了 8.8%。Dimensional Fund Advisors LP 目前持有 7,494,255 股该健康服务提供商的股票，价值 52,459,000 美元，此前在该期间内又收购了 605,061 股。Geode Capital Management LLC 在第四季度将其在 Teladoc Health 的持仓增加了 0.4%。Geode Capital Management LLC 目前持有 4,188,313 股该健康服务提供商的股票，价值 29,324,000 美元，此前在该期间内又购买了 18,394 股。Nuveen LLC 在第四季度将其在 Teladoc Health 的持仓增加了 38.7%。Nuveen LLC 目前持有 2,659,662 股该健康服务提供商的股票，价值 18,618,000 美元，此前在该期间内又购买了 742,240 股。Ameriprise Financial Inc.在第三季度将其在 Teladoc Health 的持仓增加了 11.1%。Ameriprise Financial Inc.目前持有 2,284,697 股该健康服务提供商的股票，价值 17,661,000 美元，此前在上个季度又购买了 227,385 股。最后，Man Group plc 在第四季度将其在 Teladoc Health 的持仓增加了 113.8%。Man Group plc 目前持有 1,620,633 股该健康服务提供商的股票，价值 11,344,000 美元，此前在上个季度又购买了 862,454 股。机构投资者和对冲基金持有该公司 76.82% 的股票。</p>
<h2>分析师的升级和降级</h2>
<ul>
<li>2 只曾经的疫情宠儿正在寻求 2025 年的大反转</li>
</ul>
<p>多家研究公司最近对 TDOC 发布了报告。Oppenheimer 将 Teladoc Health 的目标价从 12.00 美元下调至 7.00 美元，并在 2026 年 3 月 3 日的研究报告中对该股票给予了 “跑赢大盘” 的评级。花旗集团将 Teladoc Health 的目标价从 9.00 美元下调至 6.00 美元，并在 2026 年 3 月 3 日的报告中对该公司给予了 “中性” 评级。美国银行将 Teladoc Health 的股票评级从 “中性” 上调至 “买入”，并在 2026 年 2 月 26 日的研究报告中设定了 7.00 美元的目标价。巴克莱将 Teladoc Health 的股票目标价从 8.50 美元下调至 7.00 美元，并在 2026 年 3 月 26 日的报告中对该股票给予了 “等权重” 的评级。最后，TD Cowen 将 Teladoc Health 的股票目标价从 8.00 美元下调至 6.00 美元，并在 2026 年 2 月 26 日的研究报告中对该公司给予了 “持有” 的评级。六位股票研究分析师对该股票给予了买入评级，十三位分析师给予了持有评级，一位分析师给予了卖出评级。根据 MarketBeat 的数据，该公司的平均评级为 “持有”，平均目标价为 7.62 美元。</p>
<p><strong>查看我们对 TDOC 的最新分析</strong></p>
<h2>关于 Teladoc Health</h2>
<p>（获取免费报告）</p>
<p>Teladoc Health, Inc 是一家领先的全球虚拟医疗服务提供商，通过电话、视频和移动应用平台提供按需医疗咨询。该公司将患者与持牌医生和专家连接，以解决非紧急医疗问题、心理健康支持、皮肤病学和慢性病管理。通过利用数字技术和数据分析，Teladoc 旨在提高可及性、降低医疗成本，并通过个性化护理计划和远程监测改善患者的治疗效果。</p>
<p>Teladoc 的服务组合包括普通医疗访问、心理健康会话、复杂病例的专家医疗服务，以及旨在支持慢性病管理（如糖尿病、高血压和心脏病）的健康计划。</p>
<h2>了解更多</h2>
<ul>
<li>五只我们认为比 Teladoc Health 更好的股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRET0M?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRET0M"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 Teladoc Health 吗？</h2>
<p>在考虑 Teladoc Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Teladoc Health 并不在名单上。</p>
<p>虽然 Teladoc Health 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

TDOC

远程医疗和数字健康 ETF - GlobalX

FDHT

HEAL

<p>Teladoc Health（纽约证券交易所代码：TDOC）将于 4 月 29 日发布 2026 年第一季度财报，分析师预测每股亏损 0.3412 美元，收入为 6.138 亿美元。公司对 2026 年第一季度的每股收益（EPS）指导区间为-0.450 至-0.350，对 2026 财年的 EPS 指导区间为-1.100 至-0.700。该股票目前下跌 1.7%，交易价格为 6.00 美元，市值为 10.8 亿美元。最近的内部交易显示首席执行官 Charles Divita III 出售了股份，机构投资者持有 76.82% 的股票。Oppenheimer 和花旗集团已调整了对 TDOC 的目标价格</p>

<p>Teladoc Health (NYSE:TDOC - Get Free Report) will likely be posting its Q1 2026 results after the market closes on Wednesday, April 29th. Analysts expect Teladoc Health to post earnings of ($0.3412) per share and revenue of $613.8170 million for the quarter. Teladoc Health has set its Q1 2026 guidance at -0.450--0.350 EPS and its FY 2026 guidance at -1.100--0.700 EPS. Individuals may review the information on the company's upcoming Q1 2026 earning report for the latest details on the call scheduled for Wednesday, April 29, 2026 at 5:00 PM ET.</p>
<div class="lb-trans"><p>Teladoc Health（纽约证券交易所代码：TDOC - 获取免费报告）预计将在 2026 年 4 月 29 日星期三市场收盘后发布其 2026 年第一季度财报。分析师预计 Teladoc Health 将在本季度发布每股收益（EPS）为（$0.3412）和收入为 6.138170 亿美元。Teladoc Health 已将其 2026 年第一季度的指导范围设定为每股收益-0.450 至-0.350，并将其 2026 财年的指导范围设定为每股收益-1.100 至-0.700。个人可以查看公司即将发布的 2026 年第一季度财报的信息，以获取有关定于 2026 年 4 月 29 日下午 5:00（东部时间）的电话会议的最新详情。</p>
</div><p>Get <strong>Teladoc Health</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Teladoc Health</strong> 警报：</p>
</div><ul>
<li>Peloton Stock Is Rallying, But Can It Deliver Another 70% Upside?</li>
</ul>
<div class="lb-trans"><ul>
<li>Peloton 股票正在上涨，但它能否再交付 70% 的上涨空间？</li>
</ul>
</div><p>Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings data on Wednesday, February 25th. The health services provider reported ($0.14) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.19) by $0.05. Teladoc Health had a negative return on equity of 9.13% and a negative net margin of 7.92%.The company had revenue of $642.27 million for the quarter, compared to analyst estimates of $635.33 million. During the same quarter last year, the company posted ($0.28) earnings per share. The business's quarterly revenue was up .3% compared to the same quarter last year. On average, analysts expect Teladoc Health to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.</p>
<div class="lb-trans"><p>Teladoc Health（纽约证券交易所代码：TDOC - 获取免费报告）最近在 2026 年 2 月 25 日星期三发布了季度财报。该健康服务提供商报告本季度每股收益（EPS）为（$0.14），超出市场共识预期的（$0.19）$0.05。Teladoc Health 的股本回报率为-9.13%，净利润率为-7.92%。该公司本季度的收入为 6.4227 亿美元，而分析师预期为 6.3533 亿美元。去年同期，该公司每股收益为（$0.28）。该公司的季度收入较去年同期增长了 0.3%。分析师平均预计 Teladoc Health 在当前财年的每股收益为-$1，在下一个财年的每股收益也为-$1。</p>
</div><h2>Teladoc Health Stock Down 1.7%</h2>
<div class="lb-trans"><h2>Teladoc Health 股票下跌 1.7%</h2>
</div><p>Teladoc Health stock opened at $6.00 on Wednesday. Teladoc Health has a fifty-two week low of $4.40 and a fifty-two week high of $9.77. The company has a debt-to-equity ratio of 0.72, a quick ratio of 2.67 and a current ratio of 2.77. The company has a market capitalization of $1.08 billion, a P/E ratio of -5.26 and a beta of 2.07. The stock has a 50-day simple moving average of $5.22 and a 200-day simple moving average of $6.57.</p>
<div class="lb-trans"><p>Teladoc Health 股票在星期三开盘价为 6.00 美元。Teladoc Health 的 52 周低点为 4.40 美元，52 周高点为 9.77 美元。该公司的债务与股本比率为 0.72，速动比率为 2.67，流动比率为 2.77。该公司的市值为 10.8 亿美元，市盈率为-5.26，贝塔系数为 2.07。该股票的 50 日简单移动平均线为 5.22 美元，200 日简单移动平均线为 6.57 美元。</p>
</div><h2>Insider Buying and Selling at Teladoc Health</h2>
<div class="lb-trans"><h2>Teladoc Health 的内部买卖</h2>
</div><ul>
<li>2 Telehealth Stocks That Could Gain from Trump’s New FDA Pick</li>
</ul>
<div class="lb-trans"><ul>
<li>2 只可能受益于特朗普新 FDA 任命的远程医疗股票</li>
</ul>
</div><p>In related news, CEO Charles Divita III sold 27,731 shares of Teladoc Health stock in a transaction on Wednesday, March 11th. The shares were sold at an average price of $5.49, for a total value of $152,243.19. Following the transaction, the chief executive officer directly owned 364,784 shares in the company, valued at $2,002,664.16. This trade represents a 7.06% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.70% of the stock is currently owned by corporate insiders.</p>
<div class="lb-trans"><p>在相关消息中，首席执行官 Charles Divita III 在 2026 年 3 月 11 日星期三出售了 27,731 股 Teladoc Health 股票。该股票以平均价格 5.49 美元出售，总价值为 152,243.19 美元。交易后，首席执行官直接持有该公司 364,784 股股票，价值 2,002,664.16 美元。此交易代表其持股减少了 7.06%。该交易已在向 SEC 的备案中披露，相关信息可在 SEC 网站上查阅。目前，0.70% 的股票由公司内部人士持有。</p>
</div><h2>Institutional Trading of Teladoc Health</h2>
<div class="lb-trans"><h2>Teladoc Health 的机构交易</h2>
</div><p>Hedge funds have recently made changes to their positions in the company. Dimensional Fund Advisors LP increased its stake in shares of Teladoc Health by 8.8% during the fourth quarter. Dimensional Fund Advisors LP now owns 7,494,255 shares of the health services provider's stock worth $52,459,000 after acquiring an additional 605,061 shares during the period. Geode Capital Management LLC lifted its position in Teladoc Health by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 4,188,313 shares of the health services provider's stock valued at $29,324,000 after purchasing an additional 18,394 shares during the period. Nuveen LLC lifted its position in Teladoc Health by 38.7% in the fourth quarter. Nuveen LLC now owns 2,659,662 shares of the health services provider's stock valued at $18,618,000 after purchasing an additional 742,240 shares during the period. Ameriprise Financial Inc. boosted its holdings in Teladoc Health by 11.1% in the 3rd quarter. Ameriprise Financial Inc. now owns 2,284,697 shares of the health services provider's stock valued at $17,661,000 after purchasing an additional 227,385 shares in the last quarter. Finally, Man Group plc boosted its holdings in Teladoc Health by 113.8% in the 4th quarter. Man Group plc now owns 1,620,633 shares of the health services provider's stock valued at $11,344,000 after purchasing an additional 862,454 shares in the last quarter. Institutional investors and hedge funds own 76.82% of the company's stock.</p>
<div class="lb-trans"><p>对冲基金最近对该公司的持仓进行了调整。Dimensional Fund Advisors LP 在第四季度将其在 Teladoc Health 的股份增加了 8.8%。Dimensional Fund Advisors LP 目前持有 7,494,255 股该健康服务提供商的股票，价值 52,459,000 美元，此前在该期间内又收购了 605,061 股。Geode Capital Management LLC 在第四季度将其在 Teladoc Health 的持仓增加了 0.4%。Geode Capital Management LLC 目前持有 4,188,313 股该健康服务提供商的股票，价值 29,324,000 美元，此前在该期间内又购买了 18,394 股。Nuveen LLC 在第四季度将其在 Teladoc Health 的持仓增加了 38.7%。Nuveen LLC 目前持有 2,659,662 股该健康服务提供商的股票，价值 18,618,000 美元，此前在该期间内又购买了 742,240 股。Ameriprise Financial Inc.在第三季度将其在 Teladoc Health 的持仓增加了 11.1%。Ameriprise Financial Inc.目前持有 2,284,697 股该健康服务提供商的股票，价值 17,661,000 美元，此前在上个季度又购买了 227,385 股。最后，Man Group plc 在第四季度将其在 Teladoc Health 的持仓增加了 113.8%。Man Group plc 目前持有 1,620,633 股该健康服务提供商的股票，价值 11,344,000 美元，此前在上个季度又购买了 862,454 股。机构投资者和对冲基金持有该公司 76.82% 的股票。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师的升级和降级</h2>
</div><ul>
<li>2 Former Pandemic Darlings Eyeing a Big 2025 Turnaround</li>
</ul>
<div class="lb-trans"><ul>
<li>2 只曾经的疫情宠儿正在寻求 2025 年的大反转</li>
</ul>
</div><p>A number of research firms recently issued reports on TDOC. Oppenheimer dropped their price target on Teladoc Health from $12.00 to $7.00 and set an &#34;outperform&#34; rating on the stock in a research note on Tuesday, March 3rd. Citigroup decreased their price objective on Teladoc Health from $9.00 to $6.00 and set a &#34;neutral&#34; rating for the company in a report on Tuesday, March 3rd. Bank of America upgraded shares of Teladoc Health from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and set a $7.00 target price on the stock in a research report on Thursday, February 26th. Barclays cut their target price on shares of Teladoc Health from $8.50 to $7.00 and set an &#34;equal weight&#34; rating on the stock in a report on Thursday, March 26th. Finally, TD Cowen decreased their price target on shares of Teladoc Health from $8.00 to $6.00 and set a &#34;hold&#34; rating for the company in a research note on Thursday, February 26th. Six equities research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the company has an average rating of &#34;Hold&#34; and an average price target of $7.62.</p>
<div class="lb-trans"><p>多家研究公司最近对 TDOC 发布了报告。Oppenheimer 将 Teladoc Health 的目标价从 12.00 美元下调至 7.00 美元，并在 2026 年 3 月 3 日的研究报告中对该股票给予了 “跑赢大盘” 的评级。花旗集团将 Teladoc Health 的目标价从 9.00 美元下调至 6.00 美元，并在 2026 年 3 月 3 日的报告中对该公司给予了 “中性” 评级。美国银行将 Teladoc Health 的股票评级从 “中性” 上调至 “买入”，并在 2026 年 2 月 26 日的研究报告中设定了 7.00 美元的目标价。巴克莱将 Teladoc Health 的股票目标价从 8.50 美元下调至 7.00 美元，并在 2026 年 3 月 26 日的报告中对该股票给予了 “等权重” 的评级。最后，TD Cowen 将 Teladoc Health 的股票目标价从 8.00 美元下调至 6.00 美元，并在 2026 年 2 月 26 日的研究报告中对该公司给予了 “持有” 的评级。六位股票研究分析师对该股票给予了买入评级，十三位分析师给予了持有评级，一位分析师给予了卖出评级。根据 MarketBeat 的数据，该公司的平均评级为 “持有”，平均目标价为 7.62 美元。</p>
</div><p><strong>View Our Latest Analysis on TDOC</strong></p>
<div class="lb-trans"><p><strong>查看我们对 TDOC 的最新分析</strong></p>
</div><h2>About Teladoc Health</h2>
<div class="lb-trans"><h2>关于 Teladoc Health</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.</p>
<div class="lb-trans"><p>Teladoc Health, Inc 是一家领先的全球虚拟医疗服务提供商，通过电话、视频和移动应用平台提供按需医疗咨询。该公司将患者与持牌医生和专家连接，以解决非紧急医疗问题、心理健康支持、皮肤病学和慢性病管理。通过利用数字技术和数据分析，Teladoc 旨在提高可及性、降低医疗成本，并通过个性化护理计划和远程监测改善患者的治疗效果。</p>
</div><p>Teladoc's service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.</p>
<div class="lb-trans"><p>Teladoc 的服务组合包括普通医疗访问、心理健康会话、复杂病例的专家医疗服务，以及旨在支持慢性病管理（如糖尿病、高血压和心脏病）的健康计划。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Teladoc Health</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比 Teladoc Health 更好的股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRET0M" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NYSE&amp;Symbol=TDOC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Teladoc Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Teladoc Health 吗？</h2>
</div><p>Before you consider Teladoc Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Teladoc Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Teladoc Health 并不在名单上。</p>
</div><p>While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Teladoc Health 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Teladoc Health (TDOC) 预计将在周三发布财报